MAR 30, 2016 8:43 AM PDT

Recruiting Plant Peptides to Treat Multiple Sclerosis

WRITTEN BY: Kara Marker
Multiple Sclerosis (MS) is an autoimmune disease characterized by chronic inflammation, a result from an overexcited, misdirected immune response. A synthesized plant polypeptide called cyclotide is found in a variety of common plants, and it has the capability to reduce MS-related inflammation to the point where the disease can be curbed at a very early stage.
 

 MS is currently incurable, with available treatments to reduce the rate of progression including harsh side effects. The overactive inflammatory response causing MS stems from the destruction of myelin sheaths, the components of the nervous system that insulate nerve fibers. The current study indicating the future use of cyclotides as a more effective treatment was completed at the Medical University of Vienna and recently published in the journal PNAS.
 
“This could slow down the course of the disease in general,” said Christian Gruber, PhD, Chief Researcher at the Center for Physiology and Pharmacology at the university, said about the clinical sue of cyclotides.
 
In an animal model of MS, the research time orally administrated cyclotides and saw reduced symptoms of MS to the point where the most successful case showed no further progression of MS clinical signs. These preliminary studies mean that as soon as people start to show functional neurological problems that are characteristic of MS and receive a confirmative diagnose of MS via magnetic resonance imaging (MRI), the drug could be administered to prevent any further progression of the disease.
 
Cyclotides can be isolated from common plants like coffee, cucurbits, grass, and nightshade. It is highly advantageous that the drug develop from these macrocyclic peptides can be taken orally; most current treatments have to be administered intravenously.
 
By suppressing interleukin-2, an inflammatory cytokine that promotes the division of T lymphocytes, cyclotides reduce inflammation in patients with MS. When a reasonable cause instigates interleukin-2 production and activation of T lymphocytes, this is a protective pathway for the body. However, cases of MS are characterized by an inappropriate release of interleukin-2, leading to unnecessary inflammation, so suppressing the cytokine will successful reduce the severity of MS.
 
Additionally, cyclotide-based drugs have the potential to treat other autoimmune diseases characterized by an “overactive, misdirected immune response.”
 
Researchers from the Medical University of Vienna have authorized further development to be carried out at a pharmaceutical company called Cyxone.  A clinical trial testing the drug could begin as early as the end of 2018. More than 2.5 million people worldwide are affected by MS, and cyclotide-based drugs could be the first medication to truly make a difference in their lives.
 
 
Source:  Medical University of Vienna
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 18, 2021
Immunology
"Brainwashed" Immune Cells Help Breast Tumors Thrive
MAR 18, 2021
"Brainwashed" Immune Cells Help Breast Tumors Thrive
Immunologists have discovered a mechanism through which immune cells get recruited into breast cancer tumors, and instea ...
APR 01, 2021
Health & Medicine
Safety and Contamination Concerns Over Hemp Products
APR 01, 2021
Safety and Contamination Concerns Over Hemp Products
  When the 2018 Farm Bill legalized the regulated production of low-THC hemp, as distinct from other cannabis plant ...
APR 06, 2021
Health & Medicine
Is There an Upper Limit to the Benefits of Exercise?
APR 06, 2021
Is There an Upper Limit to the Benefits of Exercise?
By now, I am sure that you all know that one of the best ways to improve your health is by running, jogging, walking, or ...
APR 08, 2021
Immunology
What's That Frozen Pizza Doing to Your Immune System?
APR 08, 2021
What's That Frozen Pizza Doing to Your Immune System?
In a recent study, scientists found that commonly-used chemical additives added to processed foods can have toxic effect ...
APR 14, 2021
Cannabis Sciences
Medicinal Cannabis Content Labels are Inaccurate, Study Finds
APR 14, 2021
Medicinal Cannabis Content Labels are Inaccurate, Study Finds
Researchers from Massachusetts General Hospital (MGH) have found that content labels on medicinal cannabis products are ...
APR 15, 2021
Neuroscience
Alcohol Metabolism in the Brain Causes Intoxicated Behavior
APR 15, 2021
Alcohol Metabolism in the Brain Causes Intoxicated Behavior
Researchers from the University of Maryland have found that the effects of alcohol intoxication, like slurred speech and ...
Loading Comments...